Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays

Neurology

Volumn 78, Issue 9, 2012, Pages 665-671

  Waters, P J ^a   McKeon, A ^b   Leite, M I ^a   Rajasekharan, S ^c   Lennon, V A ^b   Villalobos, A ^c   Palace, J ^a   Mandrekar, J N ^b   Vincent, A ^a   Bar Or, A ^c   Pittock, S J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAYO CLINIC   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CELL ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SERODIAGNOSIS;

EID: 84858167672     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318248dec1     Document Type: Article

References (19)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805- 815.
2. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489. (Pubitemid 43958540)
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106 -2112.
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477. (Pubitemid 41186945)
5. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007;69:2221-2231. (Pubitemid 350294677)
6. Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin- 4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008;205:2473-2481.
7. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009;66:630-643.
8. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos, MC. Intra-cerebral injection of NMO-IgG and human complement produces neuromyelitis optica lesions in mice. Brain 2010;133:349 -361.
9. Kinoshita M, Nakatsuji Y, Kimura T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009;386:623- 627.
10. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009;66:617- 629.
11. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919. (Pubitemid 352008474)
12. Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68:1076-1077. (Pubitemid 46569147)
13. McKeon A, Fryer J, Apiwattanakul M, et al. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immuno-precipitation assays. Arch Neurol 2009;66:1134 -1138.
14. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1235-1243. (Pubitemid 47355956)
15. Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 2010;291:52-56.
16. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008;196:181-187.
17. De Vidi I, Boursier G, Delouche N, et al. Strategy for antiaquaporin- 4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol 2011;138:239-246.
18. Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006;210:307-13. (Pubitemid 44883971)
19. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol 2009 Sep;66:1164-1167.